Category: Forbes

Growing Human Retinas In The Lab, Scientists Spy On How Color-Detecting Cells In The Eye Develop

The new research published today suggests a potential treatment approach for premature babies with certain vision problems.

Do Nice People Fare Worse Financially?

A new study finds that “nice” people—those higher in agreeableness—may not handle money as well.

Researchers Have Created Healthy Mice From Same-Sex Parents. But Why?

Researchers in China have created healthy mice from two female parents. Why did they do it and could this lead to a way for gay and lesbian couples to have biological children together?

Walgreens Hints More Partnerships, Not Big Deals In The Future

Walgreens will escalate its partnership strategy, which the drugstore chain says effectively brings scale and market share gains across the U.S.

Medicare May Be Spending Far Less On End-Of-Life Patients Than We Think

We’ve been hearing for years that one-quarter of Medicare spending comes in the last year of life. But what if it isn’t true?

Warning For Hunters: What Bovine Tuberculosis Is Doing In Deer

What do a cow, a deer, and a hunter have in common? The answer in certain parts of Michigan may be Mycobacterium bovis, the bacteria that causes bovine tuberculosis, if hunters are not careful.

The Curious Yet Wonderful Bedfellows Of Health Tech

Coordinating healthcare logistics play a key role is patient management.

As China Hunts For New Cures, Investors Flood U.S. Biotech Firms With Cash

China is investing record amounts of money into U.S.-based healthcare and pharmaceutical startups, as it seeks to become a powerhouse in developing new medicines.

Walgreens, LabCorp To Open 600 Diagnostic Test Centers

Walgreens said it will expand a collaboration with diagnostic testing firm LabCorp. to open at least 600 patient service centers at Walgreens stores over the next four years.

A Preview Of The 2018 Forbes Healthcare Summit

The Forbes Healthcare Summit will convene in New York on November 28 and 29, gathering executives, investors, researchers and patients to imagine the healthcare system as it should be.